1 |
Kim TH, Ko YH, Lee MA, Kim BS, Chung SR, Yoo IR, et al. Treatment outcome of cisplatin based chemoradiotherapy in patients with locally advanced nasopharyngeal cancer. Cancer Res Treat. 2008;40:52-70
|
2 |
Geara FB, Sanguineti G, Tucker SL, Garden AS, Ang KK, Morrison WH, et al. Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of distant metastasis and survival. Radiother Oncol. 1997;43:53-61
DOI
ScienceOn
|
3 |
Chung WK, Cho JS, Park SJ, Lee JH, Ahn SJ, Nam TK, et al. An analysis on factors affecting local control and survival in nasopharyngeal carcinoma. J of Korean Soc Ther Radiol Oncol. 1999; 17:91-99
|
4 |
Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys. 1992;23:271-280
DOI
ScienceOn
|
5 |
Zhang L, Zhao C, Peng PJ, Lu LX, Huang PY, Han F, et al. Phase III study comparing standard radiotherapy with or without weekly oxaliplatin in treatment of locoregionally advanced nasopharyngeal carcinoma: Preliminary results. J Clin Oncol. 2005;23: 8461-8468
DOI
ScienceOn
|
6 |
Shin YS, Kim JH, Kim KR. Clinical study of malignant tumors of the nasopharynx. Korean J Otolaryngol. 1989;32:879-887
|
7 |
Spano JP, Busson P, Atlan D, Bourhis J, Pignon JP, Esteban C, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer. 2003; 39:2121-2135
DOI
ScienceOn
|
8 |
Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5,307 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261-270
DOI
ScienceOn
|
9 |
Bailet JW, Mark RJ, Abemayor E, Lee SP, Tran LM, Juillard G, et al. Nasopharyngeal carcinoma: treatment results with primary radiation therapy. Laryngoscope. 1992;102:965-972
|
10 |
Tombolini V, De Sanctis V, Donato V, Osti MF, Raffetto N, Santarelli M, et al. Prognostic features and treatment outcome in patients with nasopharyngeal carcinoma: An experience of 20 years. Anticancer Res. 2001;21:1413-1418
|
11 |
Erkal HS, Serin M, Cakmak A. Nasopharyngeal carcinomas: Analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol. 2001;61:247-256
DOI
ScienceOn
|
12 |
Su CK, Wang CC. Prognostic value of Chinese race in nasopharyngeal cancer. Int J Radiat Oncol Biol Phys. 2002;54:725-758
DOI
|
13 |
Teo P, Yu P, Lee WY, Leung SF, Kwan WH, Yu KH, et al. Significant prognostic factors after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys. 1996;36:291-304
|
14 |
Farias TP, Dias FL, Lima RA, Kligerman J, de Sa GM, Barbosa MM, et al. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129:794-799
DOI
ScienceOn
|
15 |
Fuchs S, Rodel C, Brunner T, Iro H, Niedobitek G, Sauer R, et al. Patterns of failure following radiation with and without chemotherapy in patients with nasopharyngeal carcinoma. Onkologie. 2003;26:12-18
DOI
ScienceOn
|
16 |
Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY. Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol. 2003;33:501-508
DOI
ScienceOn
|
17 |
Lin JC, Jan JS, Hsu CY, Liang WM, Jiang RS, Wang WY. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival. J Clin Oncol. 2003;21:631-637
DOI
ScienceOn
|
18 |
Sanguineti G, Geara FB, Garden AS, Tucker SL, Ang KK, Morrison WH, et al. Carcinoma of nasopharynx treated by radiotherapy alone: Determinants of local and regional control. Int J Radiat Oncol Bio Phys. 1997;37:985-996
DOI
ScienceOn
|
19 |
Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa P, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22
DOI
ScienceOn
|
20 |
Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. J Clin Oncol. 2005;23:6966-6975
DOI
ScienceOn
|